The sleep study market size is estimated to be worth US$ 6,754.2 million in 2024. The sleep study industry is anticipated to surpass US$ 12,678.6 million by 2034. The increasing prevalence of sleep disorders and awareness regarding their adverse health effects are major drivers propelling the adoption of sleep studies.
The demand for sleep study is predicted to rise at a CAGR of 6.50% through 2034. As awareness grows about the importance of quality sleep for overall well-being, more individuals seek professional diagnosis and treatment through sleep study.
| Attributes | Details |
|---|---|
| Sleep Study Market Value for 2024 | US$ 6,754.2 million |
| Sleep Study Market Value for 2034 | US$ 12,678.6 million |
| Sleep Study Market Forecast CAGR for 2024 to 2034 | 6.50% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Historical CAGR | 8.50% |
|---|---|
| Forecast CAGR | 6.50% |
The sleep study industry has shown a significant historical CAGR of 8.50%, indicating robust expansion over the specified period. This rapid growth can be attributed to several key factors, including increasing awareness about the importance of sleep health, rising prevalence of sleep disorders, advancements in sleep study technologies, and growing investment in healthcare infrastructure.
The forecasted CAGR for the sleep study market is slightly moderate at 6.50%. Several factors may have influenced this decrease in the projected growth rate. One possible factor is market saturation, as the initial surge in demand for sleep study may have plateaued over time. Additionally, regulatory challenges, reimbursement issues, and competition from alternative diagnostic methods could have impacted market growth.
Looking ahead, the market is expected to continue growing steadily, albeit at a slightly reduced rate. Factors such as ongoing research and development efforts to improve sleep study technologies, increasing adoption of telemedicine solutions, and rising awareness campaigns about sleep disorders are anticipated to support market expansion.
Principal Consultant
Increasing awareness of the importance of sleep for overall health and well-being is fueling interest in sleep studies among both individuals and healthcare providers, leading to higher demand for sleep assessment services.
The expansion of telemedicine services allows individuals to undergo sleep study remotely, eliminating the need for in-person visits to sleep centers and improving access to sleep assessment services, especially in underserved areas.
Home sleep testing is becoming increasingly popular as it is more convenient and cost-effective than in-lab sleep study. This trend is expected to continue as technology improves and becomes more accessible.
There is a growing demand for personalized treatment plans for sleep disorders. Sleep studies can help providers create customized treatment plans based on individual patient needs.
Reimbursement policies for sleep study are evolving, with many insurance providers covering the cost of sleep study. This is driving the adoption of sleep studies and is expected to continue to do so in the forecast period.
This section provides detailed insights into specific segments in the sleep study industry.
| Top Testing Services | In-Lab Testing |
|---|---|
| Market Share in 2024 | 61% |
In-lab testing emerges as the leading category, capturing a projected 61% market share in 2024. Its growth can be attributed to several factors:
| Dominating Indication Segment | Obstructive Sleep Apnea |
|---|---|
| Market Share in 2024 | 41% |
Obstructive sleep apnea (OSA) is expected to be the dominant indication segment in 2024, holding a projected market share of 41%. This dominance is driven by:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section analyzes the sleep study market across key countries, including the United States, United Kingdom, Thailand, India, and Germany. The analysis delves into the specific factors driving the demand for sleep studies in these countries.
| Countries | CAGR |
|---|---|
| United States | 5.4% |
| United Kingdom | 7.50% |
| Thailand | 12.5% |
| India | 9.81% |
| Germany | 5.17% |
The sleep study industry in the United States is projected to rise at a CAGR of 5.4% through 2034.
The sleep study industry in the United Kingdom is likely to rise at a CAGR of 7.50% through 2034.
Thailand’s sleep study industry is anticipated to witness expansion at a CAGR of 12.5% through 2034.
India's sleep study industry is projected to rise at a CAGR of 9.81% through 2034.
Germany's sleep study market is expected to rise at a 5.17% CAGR through 2034.
Traditional sleep labs, often backed by major healthcare institutions, hold a strong market position. However, smaller, independent sleep clinics are emerging, offering competitive pricing and flexible scheduling options. This necessitates established players to modernize their facilities and services to remain competitive.
Technological advancements are shaping the competitive landscape. Players offering home sleep testing (HST) kits and cloud-based platforms for data analysis are gaining traction, providing patients with convenient and cost-effective alternatives to in-lab study. Established players need to adopt these technologies and invest in research & development to maintain their edge.
Collaboration holds significant potential. Partnerships between sleep clinics and healthcare providers facilitate referrals and improve patient access to sleep study. Additionally, collaborations with technology companies can accelerate innovation and enhance the patient experience through digital tools and data integration.
Recent Developments in the Sleep Study Industry
The sleep study market is projected to expand at a CAGR of 6.50% between 2024 and 2034.
The in-lab testing segment is predicted to dominate the industry.
The top 3 sleep study providers are Circle Health Group, Cleveland Clinic, and Competence Center of Sleep Medicine.
The sleep study market is anticipated to surpass US$ 12,678.6 million by 2034.
Increased awareness about the importance of sleep health and the rising prevalence of sleep disorders are driving the demand for sleep study.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Testing Services
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Testing Services, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Testing Services, 2024 to 2034
5.3.1. Home Sleep Testing
5.3.2. In-Lab Testing
5.3.2.1. Polysomnography (PSG) Testing
5.3.2.2. CPAP/ BiPAP Titration
5.3.2.3. Split Night Polysomnography
5.3.2.4. Multiple Sleep Latency Test (MSLT)
5.3.2.5. Maintenance of Wakefulness Test (MWT)
5.3.2.6. Epilepsy Monitoring
5.4. Y-o-Y Growth Trend Analysis By Testing Services, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Testing Services, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2024 to 2034
6.3.1. Obstructive Sleep Apnoea
6.3.2. Insomnia
6.3.3. Restless Leg Syndrome
6.3.4. Circadian Rhythm Sleeping Disorders
6.3.5. Narcolepsy
6.3.6. Rapid eye movement (REM) Sleep Disorders
6.3.7. Periodic Limb Movement Disorders
6.3.8. Bruxism
6.4. Y-o-Y Growth Trend Analysis By Indication, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Indication, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2024 to 2034
7.3.1. Hospital Settings
7.3.2. Sleep Testing Centres
7.3.3. Home Care Settings
7.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Testing Services
9.2.3. By Indication
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Testing Services
9.3.3. By Indication
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Testing Services
10.2.3. By Indication
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Testing Services
10.3.3. By Indication
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Testing Services
11.2.3. By Indication
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Testing Services
11.3.3. By Indication
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Testing Services
12.2.3. By Indication
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Testing Services
12.3.3. By Indication
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Testing Services
13.2.3. By Indication
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Testing Services
13.3.3. By Indication
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Testing Services
14.2.3. By Indication
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Testing Services
14.3.3. By Indication
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Testing Services
15.2.3. By Indication
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Testing Services
15.3.3. By Indication
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Market Share Analysis, 2023
16.1.1.1. By Testing Services
16.1.1.2. By Indication
16.1.1.3. By End User
16.2. Canada
16.2.1. Market Share Analysis, 2023
16.2.1.1. By Testing Services
16.2.1.2. By Indication
16.2.1.3. By End User
16.3. Brazil
16.3.1. Market Share Analysis, 2023
16.3.1.1. By Testing Services
16.3.1.2. By Indication
16.3.1.3. By End User
16.4. Mexico
16.4.1. Market Share Analysis, 2023
16.4.1.1. By Testing Services
16.4.1.2. By Indication
16.4.1.3. By End User
16.5. Germany
16.5.1. Market Share Analysis, 2023
16.5.1.1. By Testing Services
16.5.1.2. By Indication
16.5.1.3. By End User
16.6. UK
16.6.1. Market Share Analysis, 2023
16.6.1.1. By Testing Services
16.6.1.2. By Indication
16.6.1.3. By End User
16.7. France
16.7.1. Market Share Analysis, 2023
16.7.1.1. By Testing Services
16.7.1.2. By Indication
16.7.1.3. By End User
16.8. Spain
16.8.1. Market Share Analysis, 2023
16.8.1.1. By Testing Services
16.8.1.2. By Indication
16.8.1.3. By End User
16.9. Italy
16.9.1. Market Share Analysis, 2023
16.9.1.1. By Testing Services
16.9.1.2. By Indication
16.9.1.3. By End User
16.10. Poland
16.10.1. Market Share Analysis, 2023
16.10.1.1. By Testing Services
16.10.1.2. By Indication
16.10.1.3. By End User
16.11. Russia
16.11.1. Market Share Analysis, 2023
16.11.1.1. By Testing Services
16.11.1.2. By Indication
16.11.1.3. By End User
16.12. Czech Republic
16.12.1. Market Share Analysis, 2023
16.12.1.1. By Testing Services
16.12.1.2. By Indication
16.12.1.3. By End User
16.13. Romania
16.13.1. Market Share Analysis, 2023
16.13.1.1. By Testing Services
16.13.1.2. By Indication
16.13.1.3. By End User
16.14. India
16.14.1. Market Share Analysis, 2023
16.14.1.1. By Testing Services
16.14.1.2. By Indication
16.14.1.3. By End User
16.15. Bangladesh
16.15.1. Market Share Analysis, 2023
16.15.1.1. By Testing Services
16.15.1.2. By Indication
16.15.1.3. By End User
16.16. Australia
16.16.1. Market Share Analysis, 2023
16.16.1.1. By Testing Services
16.16.1.2. By Indication
16.16.1.3. By End User
16.17. New Zealand
16.17.1. Market Share Analysis, 2023
16.17.1.1. By Testing Services
16.17.1.2. By Indication
16.17.1.3. By End User
16.18. China
16.18.1. Market Share Analysis, 2023
16.18.1.1. By Testing Services
16.18.1.2. By Indication
16.18.1.3. By End User
16.19. Japan
16.19.1. Market Share Analysis, 2023
16.19.1.1. By Testing Services
16.19.1.2. By Indication
16.19.1.3. By End User
16.20. South Korea
16.20.1. Market Share Analysis, 2023
16.20.1.1. By Testing Services
16.20.1.2. By Indication
16.20.1.3. By End User
16.21. GCC Countries
16.21.1. Market Share Analysis, 2023
16.21.1.1. By Testing Services
16.21.1.2. By Indication
16.21.1.3. By End User
16.22. South Africa
16.22.1. Market Share Analysis, 2023
16.22.1.1. By Testing Services
16.22.1.2. By Indication
16.22.1.3. By End User
16.23. Israel
16.23.1. Market Share Analysis, 2023
16.23.1.1. By Testing Services
16.23.1.2. By Indication
16.23.1.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Testing Services
17.3.3. By Indication
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Circle Health Group
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Cleveland Clinic
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. USA Sleep Diagnostic
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Imperial College Healthcare NHS Trust
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Interdisciplinary Center of Sleep Medicine
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. International Institute of Sleep
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Koninklijke Philips N.V.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Korea University Medicine
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. London Sleep Centre
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. MedStar Health
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Millennium Sleep Lab
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Sleep Study Market
